| P2093 | author name string | J K Davis | |
| | J Matt Green | |
| P2860 | cites work | Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain | Q24676705 |
| | Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice | Q28202813 |
| | Caffeine ingestion and muscle metabolism during prolonged exercise in humans | Q28320540 |
| | Effects of acute caffeine withdrawal on habituated male runners | Q30465937 |
| | Adenosine induces initial hypoxic-ischemic depression of synaptic transmission in the rat hippocampus in vivo | Q31920069 |
| | Adenosine, a metabolic trigger of the exercise pressor reflex in humans | Q32184964 |
| | Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. | Q33537215 |
| | Adenosine in sleep and wakefulness | Q33645408 |
| | K+ transport in resting rat hind-limb skeletal muscle in response to paraxanthine, a caffeine metabolite | Q33883279 |
| | Caffeine use in sports. A pharmacological review | Q33925393 |
| | Adenosine in the central nervous system: release mechanisms and extracellular concentrations | Q33955930 |
| | Effect of caffeine on perceptions of leg muscle pain during moderate intensity cycling exercise | Q33973944 |
| | Gender differences in pain | Q34154337 |
| | Effects of ephedrine, caffeine, and their combination on muscular endurance | Q34202449 |
| | Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers | Q34287858 |
| | Potassium regulation during exercise and recovery in humans: implications for skeletal and cardiac muscle | Q34295855 |
| | Nomenclature and classification of purinoceptors. | Q34324355 |
| | Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects | Q34359353 |
| | Study of Somatic Pain. | Q55180948 |
| | Direct cutaneous hyperalgesia induced by adenosine | Q56611045 |
| | The Effect of Different Dosages of Caffeine on Endurance Performance Time | Q56611050 |
| | Caffeine as an analgesic adjuvant | Q61876866 |
| | Anaerobic capacity determined by maximal accumulated O2 deficit | Q62671775 |
| | Caffeine increases maximal anaerobic power and blood lactate concentration | Q67554078 |
| | Muscle metabolism during 30, 60 and 90 s of maximal cycling on an air-braked ergometer | Q67827323 |
| | Effects of caffeine ingestion on metabolic responses to prolonged walking in sedentary males | Q67828987 |
| | The effects of caffeine on graded exercise performance in caffeine naive versus habituated subjects | Q67975692 |
| | Benefits of caffeine ingestion on sprint performance in trained and untrained swimmers | Q68134378 |
| | Fiber-type specific caffeine sensitivities in normal human skinned muscle fibers | Q68409020 |
| | Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cyclic adenosine monophosphate accumulation, and lipolysis in fat cells | Q68649451 |
| | Relative importance of aerobic and anaerobic energy release during short-lasting exhausting bicycle exercise | Q69407611 |
| | Influence of caffeine on force and EMG in rested and fatigued muscle | Q69437317 |
| | Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds | Q69844021 |
| | Glucose Turnover During Recovery from Intensive Exercise | Q70269288 |
| | The roles of catecholamines in glucoregulation in intense exercise as defined by the islet cell clamp technique | Q70869224 |
| | Effect of caffeine ingestion on perception of effort and subsequent work production | Q71128413 |
| | Extracellular adenosine levels in neostriatum and hippocampus during rest and activity periods of rats | Q71474420 |
| | Effect of caffeine on skeletal muscle function before and after fatigue | Q71766366 |
| | Caffeine Ingestion and Performance of a 1,500-Metre Swim | Q71972801 |
| | The oxygen uptake-power regression in cyclists and untrained men: implications for the accumulated oxygen deficit | Q71994317 |
| | Metabolic, catecholamine, and exercise performance responses to various doses of caffeine | Q72298504 |
| | Effects of caffeine on the metabolic and catecholamine responses to exercise in 5 and 28 degrees C | Q72507658 |
| | Caffeine attenuates the exercise-induced increase in plasma [K+] in humans | Q72967667 |
| | Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitual caffeine consumers | Q73128040 |
| | Caffeine vs caffeine-free sports drinks: effects on urine production at rest and during prolonged exercise | Q73130742 |
| | Caffeine ingestion does not alter carbohydrate or fat metabolism in human skeletal muscle during exercise | Q73300519 |
| | Hypoalgesic effect of caffeine in experimental ischemic muscle contraction pain | Q74077203 |
| | Inhibition of motor unit firing during experimental muscle pain in humans | Q74082009 |
| | Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise | Q74485761 |
| | The effects of caffeine on the maximal accumulated oxygen deficit and short-term running performance | Q74688567 |
| | Regulation of muscle glycogenolytic flux during intense aerobic exercise after caffeine ingestion | Q74831794 |
| | Effect of caffeinated drinks on substrate metabolism, caffeine excretion, and performance | Q74831916 |
| | Caffeine ingestion and metabolic responses of tetraplegic humans during electrical cycling | Q77209283 |
| | Effect of caffeine on metabolism, exercise endurance, and catecholamine responses after withdrawal | Q77369311 |
| | Caffeine, performance, and metabolism during repeated Wingate exercise tests | Q77369315 |
| | Effects of caffeine on neuromuscular function | Q78117932 |
| | The effects of caffeine ingestion on performance time, speed and power during a laboratory-based 1 km cycling time-trial | Q79225119 |
| | Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine | Q79360576 |
| | The acute effects of a caffeine-containing supplement on strength, muscular endurance, and anaerobic capabilities | Q80179142 |
| | Effect of nutritionally enriched coffee consumption on aerobic and anaerobic exercise performance | Q80388878 |
| | Gender-specific differences in electromyographic changes and perceived pain induced by experimental muscle pain during sustained contractions of the upper trapezius muscle | Q81149883 |
| | Effect of caffeine ingestion on one-repetition maximum muscular strength | Q81241810 |
| | Effects of caffeine on prolonged intermittent-sprint ability in team-sport athletes | Q82844765 |
| | Effect of caffeine on leg muscle pain during cycling exercise among females | Q82844778 |
| | Caffeine and exercise: metabolism, endurance and performance | Q34388646 |
| | Effect of caffeinated coffee on running speed, respiratory factors, blood lactate and perceived exertion during 1500-m treadmill running | Q34679581 |
| | Effect of caffeine on maximal strength and power in élite male athletes | Q34680070 |
| | Modulation of force development by Na+, K+, Na+ K+ pump and KATP channel during muscular activity. | Q34785776 |
| | Caffeine and exercise | Q35166454 |
| | Caffeine: a valuable tool to study central fatigue in humans? | Q35987170 |
| | Effects of caffeine ingestion on rating of perceived exertion during and after exercise: a meta-analysis | Q36073167 |
| | The influence of caffeine on voluntary muscle activation | Q36332370 |
| | Physiological and metabolic responses of repeated-sprint activities:specific to field-based team sports. | Q36334773 |
| | Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action. | Q36349905 |
| | Effects of ingesting JavaFit Energy Extreme functional coffee on aerobic and anaerobic fitness markers in recreationally-active coffee consumers | Q36419037 |
| | The mechanism of the action of caffeine on sarcoplasmic reticulum | Q36427879 |
| | The relationship between caffeine contracture of intact muscle and the effect of caffeine on reticulum | Q36427898 |
| | Potassium regulation during exercise and recovery. | Q36431967 |
| | Caffeine as an ergogenic aid. | Q36527798 |
| | New pharmacologic horizons in the treatment of Parkinson disease | Q36618893 |
| | Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease | Q36736573 |
| | The pain-adaptation model: a discussion of the relationship between chronic musculoskeletal pain and motor activity | Q37221071 |
| | Exercise-induced muscle fatigue: the significance of potassium | Q37990917 |
| | Physiological responses to caffeine during endurance running in habitual caffeine users. | Q38690570 |
| | The physiological role of adenosine in the central nervous system | Q39416189 |
| | Caffeine as an analgesic adjuvant in tension headache | Q39480388 |
| | Headache pain model for assessing and comparing the efficacy of over-the-counter analgesic agents | Q39507546 |
| | Purine receptors in mammalian tissues: pharmacology and functional significance | Q39767361 |
| | The role of cyclic AMP in the actions of some lipolytic and anti-lipolytic agents | Q39907442 |
| | Adenosine receptors: targets for future drugs | Q40128879 |
| | The Exercise Pressor Reflex: Its Cardiovascular Effects, Afferent Mechanisms, and Central Pathways | Q40148759 |
| | Caffeine and performance | Q40407332 |
| | Adenosine receptor subtypes: characterization and therapeutic regulation | Q40437012 |
| | Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine | Q40522857 |
| | Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortex | Q41040393 |
| | Stimulation of Na+, K(+)-pump activity in skeletal muscle by methylxanthines: evidence and proposed mechanisms | Q41054253 |
| | Oxygen deficit: a measure of the anaerobic energy production during intense exercise? | Q41199763 |
| | Group III and IV receptors in skeletal muscle: are they specific or polymodal? | Q41330769 |
| | The Role of Dopamine in the Behavioral Effects of Caffeine in Animals and Humans | Q41527844 |
| | Substance P potentiates the algogenic effects of intraarterial infusion of adenosine. | Q41662373 |
| | Caffeine ingestion and isokinetic strength | Q41862415 |
| | Contribution of energy systems during a Wingate power test | Q42152156 |
| | Adenosine injection into the brachial artery produces ischaemia like pain or discomfort in the forearm | Q42209384 |
| | Caffeine, maximal power output and fatigue | Q42409450 |
| | Adenosine receptor activation and nociception | Q43070892 |
| | Little effect of caffeine ingestion on repeated sprints in team-sport athletes | Q43589292 |
| | Effect of caffeine and ephedrine ingestion on anaerobic exercise performance | Q43688835 |
| | Caffeine increases endurance and attenuates force sensation during submaximal isometric contractions | Q43745415 |
| | Opposite actions of caffeine and creatine on muscle relaxation time in humans | Q43858058 |
| | Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease | Q43947419 |
| | Ca2+ release from sarcoplasmic reticulum of skinned fast- and slow-twitch muscle fibers | Q44052217 |
| | Effect of different protocols of caffeine intake on metabolism and endurance performance | Q44106225 |
| | On the mechanism of action of theophylline and caffeine. | Q44121344 |
| | Central nervous system effects of caffeine and adenosine on fatigue | Q44193704 |
| | Caffeine is ergogenic after supplementation of oral creatine monohydrate | Q44221175 |
| | Dose-dependent effect of caffeine on reducing leg muscle pain during cycling exercise is unrelated to systolic blood pressure | Q44906062 |
| | Caffeine lowers perceptual response and increases power output during high-intensity cycling | Q45061199 |
| | Effects of caffeine ingestion on exercise testing: a meta-analysis | Q45229178 |
| | The impact of prior coffee consumption on the subsequent ergogenic effect of anhydrous caffeine | Q45229183 |
| | Blood glucose turnover during high- and low-intensity exercise. | Q46009026 |
| | Actions of caffeine on fast- and slow-twitch muscles of the rat. | Q46122100 |
| | Wingate performance and surface EMG frequency variables are not affected by caffeine ingestion | Q46134131 |
| | Effects of caffeine on repetitions to failure and ratings of perceived exertion during resistance training. | Q46147665 |
| | Effects of caffeine ingestion on metabolism and exercise performance | Q46188614 |
| | Caffeine increases time to fatigue by maintaining force and not by altering firing rates during submaximal isometric contractions | Q46477494 |
| | The effect of ephedra and caffeine on maximal strength and power in resistance-trained athletes. | Q46542504 |
| | Multiple effects of caffeine on simulated high-intensity team-sport performance | Q46803083 |
| | Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine | Q48761592 |
| | Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. | Q48795778 |
| | Blood-brain barrier transport of caffeine: dose-related restriction of adenine transport | Q48859774 |
| | Sensory-motor interactions of human experimental unilateral jaw muscle pain: a quantitative analysis | Q49136274 |
| | Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. | Q51596739 |
| | Effects of Caffeine Ingestion on Performance and Anaerobic Metabolism during the Wingate Test | Q51609294 |
| | Analgesic effect of bamiphylline on pain induced by intradermal injection of adenosine. | Q51665508 |
| | Physiological and cognitive responses to caffeine during repeated, high-intensity exercise. | Q51769774 |
| | Effect of Experimental Muscle Pain on Motor Unit Firing Rate and Conduction Velocity | Q51798815 |
| | The effects of caffeine on athletic agility. | Q54004248 |
| | Comparison of caffeine and theophylline ingestion: exercise metabolism and endurance. | Q54134183 |
| | Influence of two levels of caffeine on maximal torque at selected angular velocities | Q54295672 |
| | Caffeine attenuates delayed-onset muscle pain and force loss following eccentric exercise. | Q55042834 |
| | Performance and metabolic responses to a high caffeine dose during prolonged exercise | Q55044504 |
| | Caffeine counteracts the ergogenic action of muscle creatine loading. | Q55066784 |
| | Naturally occurring muscle pain during exercise: assessment and experimental evidence. | Q55067170 |
| P433 | issue | 10 | |
| P304 | page(s) | 813-832 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Sports Medicine | Q15762097 |
| P1476 | title | Caffeine and anaerobic performance: ergogenic value and mechanisms of action | |
| P478 | volume | 39 | |